Ethics
The study was designed collaboratively by the sponsor and lead study investigators. The protocol was approved by the sites’ institutional review boards and conducted in accordance with the Declaration of Helsinki. All patients provided written informed consent. An independent Data Monitoring Committee reviewed safety data approximately every 6 months. All authors had access to the results and analyzed them in collaboration with the sponsor.